Loading clinical trials...
Loading clinical trials...
Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia
Conditions
Interventions
Raphamin
Placebo
Locations
38
Russia
Aramil city hospital
Aramil, Russia
Northern Medical Clinical Center named after N.A. Semashko Federal Medical and Biological Agency
Arkhangelsk, Russia
Gatchina Clinical Interdistrict Hospital
Gatchina, Russia
Ivanovo Clinical Hospital named after Kuvayevs
Ivanovo, Russia
City Clinical Hospital # 9 of the Ministry of Health of the Udmurt Republic
Izhevsk, Russia
Central City Clinical Hospital
Kaliningrad, Russia
Start Date
December 1, 2023
Primary Completion Date
March 19, 2025
Completion Date
March 19, 2025
Last Updated
April 4, 2025
NCT07388680
NCT07428759
NCT05041140
NCT06743529
NCT07344714
NCT07409727
Lead Sponsor
Materia Medica Holding
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions